Market Overview:
The global bethanechol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of gastrointestinal disorders, increasing geriatric population, and growing demand for Bethanechol tablets. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, Bethanechol tablets are expected to account for a major share of the global bethanechol market in 2018. This can be attributed to their ease-of-use and better patient compliance as compared with other forms such as injections and oral solutions. Based on application, oral applications are anticipated to dominate the global bethanechol market in 2018 owing to their widespread use across various indications such as urinary retention, postoperative ileus (POI), and neurogenic bladder dysfunction (NBD).
Product Definition:
Bethanechol is a drug that is used to help people who have problems with urination.
5mg:
Bethanechol is a chiral compound of 5-membered saturated heterocyclic base, which is also named as 1-bethoxyvinyl chloride. It has no optical activity and hence it's not an ester. Bethanechol can be synthesized by several methods, one of them being the synthesis from vinyl chloride and bromoacetone (1-bromoethylene).
10mg:
Bethanechol is a chiral compound of natural origin, which is used as an oral drug to treat diarrhea and other stomach disorders. It works by relaxing the smooth muscles of the GI tract, allowing contents to move through more quickly. Bethanechol also has some mild anti-inflammatory properties that reduce swelling and redness caused by inflammation.
Application Insights:
Oral application dominated the overall industry in terms of revenue share in 2017. The oral route is considered more convenient for administration as compared to other routes. However, this may vary from patient to patient and depends on the tolerance developed towards the drug by the individual. As a result, subcutaneous injections are generally used as an alternative method for delivering cholera toxin; however, this procedure is not without risks either.
The presence of multiple manufacturers coupled with growing demand from various end-use industries such as pharmaceuticals and biotechnology has resulted in rising competition amongst market players which eventually led to low penetration rates observed for bethanechol products till date within these sectors; therefore driving its demand within oral applications only over recent years. Oral bethanechol products are available in different forms such as tablets & capsules (25mg/50mg), liquid (10 mg/ml) and powder (5 mg/kg).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of increasing use of bethanechol for treating various skin disorders and cancer. In addition, rising prevalence of acne among teenagers is anticipated to fuel regional product demand.
Asia Pacific accounted for a revenue share of over 15% in 2017 owing to high unmet clinical needs coupled with rapidly growing geriatric population base in countries such as China and India. Moreover, increasing awareness regarding early diagnosis among patients is likely to propel regional growth during the forecast period.
In 2016, Europe was one of the largest consumers as well as producers owing to availability at a lower price compared with North America.
Growth Factors:
- Increasing geriatric population: The Bethanechol market is expected to grow significantly in the next few years, owing to the increasing geriatric population. This segment of the population is more prone to urinary retention and other Bethanechol-related disorders.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as diabetes and hypertension is rising rapidly, which is likely to increase the demand for Bethanechol in the coming years.
- Growing awareness about Bethanechol benefits: There has been a significant rise in awareness about the benefits of using Bethanechol among patients and healthcare professionals in recent years. This is likely to boost demand for this drug in the coming years.
- Technological advancements: The development of new delivery systems and formulations for Bethanechol will help fuel its growth over the forecast period. These technological advancements are expected to make it easier for patients to use this drug, thereby driving its demand further up.. 5) Availability of generic versions: A number if generic versions of Betahnecho are available in various countries across the globe, which helps keep prices low and increases accessibility
Scope Of The Report
Report Attributes
Report Details
Report Title
Bethanechol Market Research Report
By Type
5mg, 10mg, 25mg, 50mg
By Application
Oral, Subcutaneous
By Companies
Amneal Pharm, Eci Pharms, Heritage Pharma, Lannett, Upsher Smith Labs, Wockhardt, Chartwell Rx, Paladin Labs, Glenwood, Sun Pharmaceutical, Odyssey Pharmaceuticals, Able Laboratories, Actavis Totowa, Amneal Pharmaceutical, Ascot Hosp Pharmaceuticals, Div Travenol Laboratories, Emcure Pharmaceuticals Usa, Impax Laboratories, Wellspring Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Bethanechol Market Report Segments:
The global Bethanechol market is segmented on the basis of:
Types
5mg, 10mg, 25mg, 50mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral, Subcutaneous
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amneal Pharm
- Eci Pharms
- Heritage Pharma
- Lannett
- Upsher Smith Labs
- Wockhardt
- Chartwell Rx
- Paladin Labs
- Glenwood
- Sun Pharmaceutical
- Odyssey Pharmaceuticals
- Able Laboratories
- Actavis Totowa
- Amneal Pharmaceutical
- Ascot Hosp Pharmaceuticals
- Div Travenol Laboratories
- Emcure Pharmaceuticals Usa
- Impax Laboratories
- Wellspring Pharmaceutical
Highlights of The Bethanechol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5mg
- 10mg
- 25mg
- 50mg
- By Application:
- Oral
- Subcutaneous
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bethanechol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bethanechol is a medication used to treat nausea and vomiting. It is also used to prevent motion sickness.
Some of the key players operating in the bethanechol market are Amneal Pharm, Eci Pharms, Heritage Pharma, Lannett, Upsher Smith Labs, Wockhardt, Chartwell Rx, Paladin Labs, Glenwood, Sun Pharmaceutical, Odyssey Pharmaceuticals, Able Laboratories, Actavis Totowa, Amneal Pharmaceutical, Ascot Hosp Pharmaceuticals, Div Travenol Laboratories, Emcure Pharmaceuticals Usa, Impax Laboratories, Wellspring Pharmaceutical.
The bethanechol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bethanechol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bethanechol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bethanechol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bethanechol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bethanechol Market Size & Forecast, 2018-2028
4.5.1 Bethanechol Market Size and Y-o-Y Growth
4.5.2 Bethanechol Market Absolute $ Opportunity
Chapter 5 Global Bethanechol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bethanechol Market Size Forecast by Type
5.2.1 5mg
5.2.2 10mg
5.2.3 25mg
5.2.4 50mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bethanechol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bethanechol Market Size Forecast by Applications
6.2.1 Oral
6.2.2 Subcutaneous
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bethanechol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bethanechol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bethanechol Analysis and Forecast
9.1 Introduction
9.2 North America Bethanechol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bethanechol Market Size Forecast by Type
9.6.1 5mg
9.6.2 10mg
9.6.3 25mg
9.6.4 50mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bethanechol Market Size Forecast by Applications
9.10.1 Oral
9.10.2 Subcutaneous
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bethanechol Analysis and Forecast
10.1 Introduction
10.2 Europe Bethanechol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bethanechol Market Size Forecast by Type
10.6.1 5mg
10.6.2 10mg
10.6.3 25mg
10.6.4 50mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bethanechol Market Size Forecast by Applications
10.10.1 Oral
10.10.2 Subcutaneous
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bethanechol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bethanechol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bethanechol Market Size Forecast by Type
11.6.1 5mg
11.6.2 10mg
11.6.3 25mg
11.6.4 50mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bethanechol Market Size Forecast by Applications
11.10.1 Oral
11.10.2 Subcutaneous
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bethanechol Analysis and Forecast
12.1 Introduction
12.2 Latin America Bethanechol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bethanechol Market Size Forecast by Type
12.6.1 5mg
12.6.2 10mg
12.6.3 25mg
12.6.4 50mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bethanechol Market Size Forecast by Applications
12.10.1 Oral
12.10.2 Subcutaneous
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bethanechol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bethanechol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bethanechol Market Size Forecast by Type
13.6.1 5mg
13.6.2 10mg
13.6.3 25mg
13.6.4 50mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bethanechol Market Size Forecast by Applications
13.10.1 Oral
13.10.2 Subcutaneous
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bethanechol Market: Competitive Dashboard
14.2 Global Bethanechol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amneal Pharm
14.3.2 Eci Pharms
14.3.3 Heritage Pharma
14.3.4 Lannett
14.3.5 Upsher Smith Labs
14.3.6 Wockhardt
14.3.7 Chartwell Rx
14.3.8 Paladin Labs
14.3.9 Glenwood
14.3.10 Sun Pharmaceutical
14.3.11 Odyssey Pharmaceuticals
14.3.12 Able Laboratories
14.3.13 Actavis Totowa
14.3.14 Amneal Pharmaceutical
14.3.15 Ascot Hosp Pharmaceuticals
14.3.16 Div Travenol Laboratories
14.3.17 Emcure Pharmaceuticals Usa
14.3.18 Impax Laboratories
14.3.19 Wellspring Pharmaceutical
